Board hears calls to ease pharmacy barriers to buprenorphine as providers, advocates describe denied fills and delays

Emergency and addiction clinicians, patient navigators and national addiction organizations told the California Board of Pharmacy on Feb. 6 that pharmacies are often the bottleneck when patients started on buprenorphine in emergency departments try to fill their first prescription.

Clinicians described repeated episodes in which patients arriving at community pharmacies — sometimes in withdrawal or with traumatic social circumstances — were refused fills, told the pharmacy had no stock, or faced denials because pharmacists applied “red flag” rules without contacting prescribers. Tommy Trevino, a substance‑use navigator at UC Davis Medical Center, said a patient he accompanied to a pharmacy was refused and staff threatened to call police; he said the episode ended only after the team returned to the hospital and arranged medication by other means.

Why it matters: Buprenorphine and other medications for opioid use disorder (MOUD) are proven to reduce overdose risk. Presenters argued that when community pharmacists treat buprenorphine like other higher‑risk opioids or strictly enforce early‑refill rules, patients who are ready for treatment may instead return to use and face higher overdose risk.

What presenters told the board - Clinical teams described three recurring, related barriers: lack of stock at local pharmacies; pharmacists’ decisions to deny fills based on “red flags” (multiple prescriptions, same address, nervous behavior); and limited, unreliable means for pharmacists to reach prescribers to resolve questions. - Brian Hurley, president of the American Society of Addiction Medicine, urged the board to treat buprenorphine differently from full‑agonist opioids and to revise pharmacy guidance that was written before wide use of MOUD. - Dr. Mullen, an emergency and addiction medicine physician involved with California Bridge, summarized the public‑health aim: “Our goal is to expand access to medication treatment,” and said pharmacy refusal for first fills is a frequent breakdown in the care pathway from emergency departments into outpatient treatment.

Discussion and board reaction Board members expressed support for more pharmacist education and clearer guidance. Several members — including President Seung Oh — said staff should open conversations with related state boards and stakeholders. Board members suggested these options: revise the Board of Pharmacy’s “red flags” guidance to remove stigmatizing or outdated language; develop education for pharmacists on corresponding responsibility and how to resolve concerns without leaving patients without medication; and coordinate outreach with the Medical Board, Nursing Board and insurer stakeholders to address billing and access issues.

Formal direction The board did not take formal regulatory or disciplinary action during the presentation. Instead members asked staff to place the issue on committee agendas for follow‑up: potential revisions to Board of Pharmacy guidance, an education campaign for pharmacists, and outreach to the Medical Board and other licensing entities about creating clearer lines for pharmacist‑prescriber communication.

Public comment and scope More than a dozen clinicians, pharmacists and navigators commented during public comment; speakers described regional supply problems and insurance or benefit design that places injectable or long‑acting agents on medical instead of pharmacy benefits, creating billing barriers for pharmacies to stock and dispense those products.

Where this goes next Board members said the Communication and Public Education Committee and the Enforcement Committee should examine the issues and return recommendations. Members also asked staff to explore legislative or regulatory options to facilitate prescriber–pharmacist communication and to consider pilot models (for example collaborative practice and mobile pharmacy services) that could expand safe, accessible MOUD dispensing.

Ending Board members thanked the presenters and said staff would follow up with stakeholders. No rulemaking, enforcement action or vote occurred at the meeting; the board asked staff to report options and a possible action plan in a future meeting.